← Back to Search

Physical Activity Program for Breast Cancer (MFT4 Trial)

N/A
Waitlist Available
Led By Bernardine M. Pinto, PhD
Research Sponsored by University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ambulatory
Able to walk unassisted
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month intervention
Awards & highlights

Summary

This trialwill measure effects of a 3-month physical activity intervention on breast cancer survivors not currently active. A web-based platform and virtual calls with a peer coach will be used to increase activity. Participants will be given a Fitbit to monitor activity.

Who is the study for?
This trial is for breast cancer survivors diagnosed within the last 5 years, who are currently inactive. They should be able to walk unassisted, read and speak English, and have access to a smartphone with Bluetooth and internet. Participants must not engage in more than 30 minutes of vigorous or 90 minutes of moderate-intensity physical activity weekly.
What is being tested?
The study tests if guidance from a peer coach can help increase moderate-intensity physical activity over three months compared to self-monitoring. Participants will be randomly placed into two groups: one receiving weekly virtual coaching and the other monitoring their own activity levels. Both groups get a Fitbit.
What are the potential side effects?
Since this trial involves increasing physical activity, potential side effects may include muscle soreness, fatigue, or injury due to exercise. However, these risks are generally low as activities are moderate in intensity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can walk on my own without help.
Select...
I can walk by myself without help.
Select...
I was diagnosed with Stage 0-3 breast cancer in the last 5 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3-month intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Accelerometer measured moderate-to-vigorous activity
Secondary study objectives
Self-Reported Fatigue
Self-Reported Mood
Self-Reported Physical Functioning
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: webMFTExperimental Treatment1 Intervention
Survivors randomized to webMFT will receive the evidence-based intervention for moderate-to-vigorous physical activity (MVPA) promotion that consists of MVPA counseling matched to patients' motivational readiness, and self-monitoring of MVPA (via Fitbit Inspire 2). The goal for the 3-month program will be to gradually increase the amount of moderate-intensity aerobic exercise that is performed, to the current national recommendations of at least 150 minutes of MPVA per week. Our goal is to promote aerobic exercise that is safe and enjoyable, such as walking.
Group II: MVPA trackingActive Control1 Intervention
These survivors will be asked to self-monitor moderate-to-vigorous physical activity (MVPA) participation by wearing the Fitbit Inspire 2 each day over 12 weeks. This group will not receive the MVPA counseling from the coaches.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverOTHER
1,786 Previous Clinical Trials
2,787,540 Total Patients Enrolled
29 Trials studying Breast Cancer
6,821 Patients Enrolled for Breast Cancer
University of South CarolinaLead Sponsor
217 Previous Clinical Trials
121,297 Total Patients Enrolled
4 Trials studying Breast Cancer
763 Patients Enrolled for Breast Cancer
InquisitHealth, Inc.OTHER
2 Previous Clinical Trials
336 Total Patients Enrolled

Media Library

Physical activity adoption Clinical Trial Eligibility Overview. Trial Name: NCT05409664 — N/A
Breast Cancer Research Study Groups: MVPA tracking, webMFT
Breast Cancer Clinical Trial 2023: Physical activity adoption Highlights & Side Effects. Trial Name: NCT05409664 — N/A
Physical activity adoption 2023 Treatment Timeline for Medical Study. Trial Name: NCT05409664 — N/A
~3 spots leftby Oct 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top